InsidersTradesSigma
PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023: insider trades · Italy · Consob
CONSOB:pharmanutra-interim-managment-report-as-of-30-september-2023IT·ConsobMcap 862M€Healthcare
Discover the full insider trade history of PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023, a listed issuer based in Italy. Shares are listed on IT IT, under the supervision of Consob. Operating in the Healthcare sector, PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023 has logged 1 insider filings. Market capitalisation: €861.8m. The latest transaction was filed on 10 November 2023 — Other. Among the most active insiders: Unknown. All data is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
90.00 €
Analyst consensus
3 analystsStrong buy
76.00 €Target 81.33 €(-10%)86.00 €
Income statement
Revenue132.9 M€
Gross profit102.9 M€77% margin
Net income20.0 M€15.2% margin
Valuation
PER (trailing)40.9x
PER (forward)29.4x
P/Book12.1x
Balance sheet & cash
Market cap861.8 M€
Total debt20.5 M€
Free Cash Flow16.4 M€
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.1%
% insiders65.0%
% institutions16.1%
Last declaration on 10 November 2023
Declarations1 total
Executives●Other0Consob
CONSOB:139010·details not loaded
1 of 1 declaration